FUROSCIX® (furosemide injection) 80 mg/10 mL for …
FUROSCIX is a prescription medicine used to treat fluid buildup, which can cause congestion or swelling (also known as edema), in patients with chronic heart failure or chronic kidney …
FUROSCIX® | Subcutaneous Formulation of Furosemide to Treat …
(furosemide injection), 80 mg/10 mL for subcutaneous use is indicated for the treatment of edema (i.e., congestion, fluid overload, or hypervolemia) in adult patients with chronic heart failure or chronic kidney disease (CKD), including the nephrotic syndrome.
Furoscix: Uses, Dosage, Side Effects, Warnings - Drugs.com
What is Furoscix? Furoscix is a loop diuretic that may be used to treat edema in adults with chronic heart failure or chronic kidney disease, including the nephrotic syndrome. Furoscix is administered by subcutaneous infusion at home by you or your caregiver with the use of the Furoscix On-Body Infusor.
FUROSCIX is a loop diuretic indicated for the treatment of edema in adult patients with chronic heart failure or chronic kidney disease, including the nephrotic syndrome. (1) See Full Prescribing...
Prescribing Information and Instructions for Use - FUROSCIX ...
Furoscix is an investigational, proprietary, pH-neutral formulation of furosemide for subcutaneous administration via an on-body infusor for the outpatient treatment of edema and congestion in patients with HF.
Furoscix (Furosemide Injection): Side Effects, Uses, Dosage ... - RxList
2025年3月21日 · FUROSCIX is a single-dose prefilled cartridge co-packaged with a single-use, on-body infusor. The single-dose prefilled cartridge contains 80 mg per 10 mL sterile, clear to slightly yellow, and nonpyrogenic furosemide solution. The pH of FUROSCIX, 7.4, differs from that of Furosemide Injection, USP.
label - Food and Drug Administration
FUROSCIX is indicated for the treatment of congestion due to fluid overload in adult patients with New York Heart Association (NYHA) Class II and Class III chronic heart failure. FUROSCIX is...
FUROSCIX- furosemide injection 80 mg/ 10 ml injection - DailyMed
2025年3月12日 · FUROSCIX is indicated for the treatment of edema in adult patients with chronic heart failure or chronic kidney disease (CKD), including the nephrotic syndrome.
在家就能用！充血性心衰患者，迎来首个皮下给药利尿剂
2022年10月13日 · Furoscix是一种通过体内输液器输送的呋塞米专利制剂，可供患者在家自行使用。 在一项临床研究中，Furoscix的生物利用度达到99.6%，患者8小时尿量为2.7L，与静脉输注的呋塞米具有等效的利尿作用。
FDA批准治疗充血性心力衰竭皮下制剂 - Pharmcube
2022年10月11日 · 10月10日，scPharmaceuticals宣布，呋塞米皮下注射液（Furoscix）已获FDA批准上市，用于治疗患有II/III级慢性心力衰竭的成人患者因液体过载引起的充血。 Furoscix跃升为全球首款皮下循环利尿剂，可供患者在家自行使用。